News
Investing.com -- Software (ETR: SOWGn) giant Adobe (NASDAQ: ADBE) announced the launch of Acrobat Studio on Tuesday, a new ...
Investing.com -- Novo Nordisk and Eli Lilly (NYSE: LLY) shares edged higher Tuesday following results from Viking Therapeutics’ Phase 2 VENTURE-Oral Dosing trial for its oral obesity treatment. Novo ...
Investing.com -- RBC Capital Markets has reaffirmed its bullish stance on Centrica (LON: CNA) following the company’s ...
Investing.com -- PTC Therapeutics, Inc. (NASDAQ: PTCT) stock fell 5% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application ...
Still, mutual funds’ A-share holdings increased by just RMB145.6 billion in the first half. UBS estimates they will need to ...
Investing.com -- Peabody Energy (NYSE: BTU) stock jumped 9% after the coal producer announced it has terminated its planned ...
Investing.com -- Treasury Secretary Bessent announced plans to increase tariffs on India due to its purchase of Russian oil, ...
BofA said Palo Alto delivered “impressive performance on all fronts,” with next-generation security annual recurring revenue ...
William Blair projected significant long-term value for Tesla’s robotaxi business. The note assumes total rideshare miles of ...
Following the transaction’s close, NorthWestern’s Brian Bird will serve as CEO of the combined company, which will be ...
Following the strong performance, Medtronic (NYSE: MDT) raised its fiscal 2026 earnings guidance to between $5.60 and $5.66 ...
Investing.com -- Viking Therapeutics (NASDAQ: VKTX) stock fell 21% Tuesday morning despite announcing positive Phase 2 trial results for its oral obesity drug that showed significant weight loss in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results